141 related articles for article (PubMed ID: 29736008)
1. Psychological impact of providing women with personalised 10-year breast cancer risk estimates.
French DP; Southworth J; Howell A; Harvie M; Stavrinos P; Watterson D; Sampson S; Evans DG; Donnelly LS
Br J Cancer; 2018 Jun; 118(12):1648-1657. PubMed ID: 29736008
[TBL] [Abstract][Full Text] [Related]
2. What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
French DP; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Howell A; Jerrison A; Machin M; Maxwell AJ; McWilliams L; Payne K; Qureshi N; Ruane H; Sampson S; Stavrinos P; Thorpe E; Ulph F; van Staa T; Woof V; Evans DG
BMC Cancer; 2020 Jun; 20(1):570. PubMed ID: 32552763
[TBL] [Abstract][Full Text] [Related]
3. A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
Wong XY; Chong KJ; van Til JA; Wee HL
BMC Cancer; 2017 Nov; 17(1):776. PubMed ID: 29162038
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
5. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
[TBL] [Abstract][Full Text] [Related]
7. Psychological impact of risk-stratified screening as part of the NHS Breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).
French DP; McWilliams L; Bowers S; Woof VG; Harrison F; Ruane H; Hendy A; Evans DG
Br J Cancer; 2023 Apr; 128(8):1548-1558. PubMed ID: 36774447
[TBL] [Abstract][Full Text] [Related]
8. The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort.
Brain K; Parsons E; Bennett P; Cannings-John R; Hood K
Psychooncology; 2011 Sep; 20(9):984-91. PubMed ID: 20677331
[TBL] [Abstract][Full Text] [Related]
9. Anxiety and specific distress in women at intermediate and high risk of breast cancer before and after surveillance by magnetic resonance imaging and mammography versus standard mammography.
Brédart A; Kop JL; Fall M; Pelissier S; Simondi C; Dolbeault S; Livartowski A; Tardivon A;
Psychooncology; 2012 Nov; 21(11):1185-94. PubMed ID: 21812069
[TBL] [Abstract][Full Text] [Related]
10. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
[TBL] [Abstract][Full Text] [Related]
11. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40-49 years - could it be better?
Oblak T; Zadnik V; Krajc M; Lokar K; Zgajnar J
Radiol Oncol; 2020 Jul; 54(3):335-340. PubMed ID: 32614783
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS
J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088
[TBL] [Abstract][Full Text] [Related]
15. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
Amir E; Evans DG; Shenton A; Lalloo F; Moran A; Boggis C; Wilson M; Howell A
J Med Genet; 2003 Nov; 40(11):807-14. PubMed ID: 14627668
[TBL] [Abstract][Full Text] [Related]
17. The cancer worry chart: a single-item screening measure of worry about developing breast cancer.
Gramling R; Anthony D; Frierson G; Bowen D
Psychooncology; 2007 Jun; 16(6):593-7. PubMed ID: 17096453
[TBL] [Abstract][Full Text] [Related]
18. Variation in Breast Cancer Risk Model Estimates Among Women in Their 40s Seen in Primary Care.
Schonberg MA; Karamourtopoulos M; Pinheiro A; Davis RB; Sternberg SB; Mehta TS; Gilliam EA; Tung NM
J Womens Health (Larchmt); 2022 Apr; 31(4):495-502. PubMed ID: 35073183
[No Abstract] [Full Text] [Related]
19. Breast cancer worry and mammography use by women with and without a family history in a population-based sample.
Andersen MR; Smith R; Meischke H; Bowen D; Urban N
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):314-20. PubMed ID: 12692105
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
